Drugs
-
?
-
Drug Safety and Availability
Information for consumers and health professionals on new drug warnings and other safety information, drug label changes, and shortages of medically necessary drug products.
-
Drug Safety Communications
- FDA Drug Safety Communication: Safety review update of Chantix (varenicline) and risk of cardiovascular adverse events
- FDA Drug Safety Communication: FDA approves label changes for zolpidem products, including new dosing and a recommendation to avoid driving the day after Ambien CR use
- FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)
-
-
Drug Recalls
- Sandoz US Announces Voluntary Nationwide Recall of two lots of Methotrexate Sodium, USP, Injectable Vials, 25mg/mL, 40mL vials
- Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
- Beamonstar Products Issues Voluntary Nationwide Recall of SexVoltz, Velextra, & Amerect Marketed as a Dietary Supplement, Due to Undeclared Active Ingredients
?
-
-
